BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 29225091)

  • 1. Gene expression profiling of the TRIM protein family reveals potential biomarkers for indicating tuberculosis status.
    Chen Y; Cao S; Sun Y; Li C
    Microb Pathog; 2018 Jan; 114():385-392. PubMed ID: 29225091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression profiling of TRIM gene family reveals potential diagnostic biomarkers for rifampicin-resistant tuberculosis.
    Liu S; Sun Y; Yang R; Ren W; Li C; Tang S
    Microb Pathog; 2021 Aug; 157():104916. PubMed ID: 34000303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reprogramming of Small Noncoding RNA Populations in Peripheral Blood Reveals Host Biomarkers for Latent and Active Mycobacterium tuberculosis Infection.
    de Araujo LS; Ribeiro-Alves M; Leal-Calvo T; Leung J; Durán V; Samir M; Talbot S; Tallam A; Mello FCQ; Geffers R; Saad MHF; Pessler F
    mBio; 2019 Dec; 10(6):. PubMed ID: 31796535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide transcriptional profiling identifies potential signatures in discriminating active tuberculosis from latent infection.
    Pan L; Wei N; Jia H; Gao M; Chen X; Wei R; Sun Q; Gu S; Du B; Xing A; Zhang Z
    Oncotarget; 2017 Dec; 8(68):112907-112916. PubMed ID: 29348876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of unique key genes and miRNAs in latent tuberculosis infection by network analysis.
    Lin Y; Zhang Y; Yu H; Tian R; Wang G; Li F
    Mol Immunol; 2019 Aug; 112():103-114. PubMed ID: 31082644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Gene Expression of ASUN, NEMF, PTPRC and DHX29: Candidate Biomarkers for the Diagnosis of Active and Latent Tuberculosis.
    Mamishi S; Pourakbari B; Sadeghi RH; Marjani M; Mahmoudi S
    Infect Disord Drug Targets; 2021; 21(2):268-273. PubMed ID: 32167431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiling identifies candidate biomarkers for active and latent tuberculosis.
    Lee SW; Wu LS; Huang GM; Huang KY; Lee TY; Weng JT
    BMC Bioinformatics; 2016 Jan; 17 Suppl 1(Suppl 1):3. PubMed ID: 26818387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease.
    Won EJ; Choi JH; Cho YN; Jin HM; Kee HJ; Park YW; Kwon YS; Kee SJ
    J Infect; 2017 Mar; 74(3):281-293. PubMed ID: 27871809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel biomarkers distinguishing active tuberculosis from latent infection identified by gene expression profile of peripheral blood mononuclear cells.
    Lu C; Wu J; Wang H; Wang S; Diao N; Wang F; Gao Y; Chen J; Shao L; Weng X; Zhang Y; Zhang W
    PLoS One; 2011; 6(8):e24290. PubMed ID: 21904626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential Immunological Biomarkers for Detection of Mycobacterium tuberculosis Infection in a Setting Where M. tuberculosis Is Endemic, Ethiopia.
    Teklu T; Kwon K; Wondale B; HaileMariam M; Zewude A; Medhin G; Legesse M; Pieper R; Ameni G
    Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29311240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential novel markers to discriminate between active and latent tuberculosis infection in Chinese individuals.
    Bai XJ; Liang Y; Yang YR; Feng JD; Luo ZP; Zhang JX; Wu XQ
    Comp Immunol Microbiol Infect Dis; 2016 Feb; 44():8-13. PubMed ID: 26851588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving T-cell assays for diagnosis of latent TB infection: Confirmation of the potential role of testing Interleukin-2 release in Iranian patients.
    Mamishi S; Pourakbari B; Shams H; Marjani M; Mahmoudi S
    Allergol Immunopathol (Madr); 2016; 44(4):314-21. PubMed ID: 26786720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of mycobacterial bacterioferritin B for immune screening of tuberculosis and latent tuberculosis infection.
    Yang X; Wu JB; Liu Y; Xiong Y; Ji P; Wang SJ; Chen Y; Zhao GP; Lu SH; Wang Y
    Tuberculosis (Edinb); 2017 Dec; 107():119-125. PubMed ID: 29050758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling the human immune response to Mycobacterium tuberculosis by human cytokine array.
    Chen T; Li Z; Yu L; Li H; Lin J; Guo H; Wang W; Chen L; Zhang X; Wang Y; Chen Y; Liao Q; Tan Y; Shu Y; Huang W; Cai C; Zhou Z; Yu M; Li G; Zhou L; Zhong Q; Bi L; Zhao M; Guo L; Zhou J
    Tuberculosis (Edinb); 2016 Mar; 97():108-17. PubMed ID: 26980502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granzyme A as a potential biomarker of Mycobacterium tuberculosis infection and disease.
    Guggino G; Orlando V; Cutrera S; La Manna MP; Di Liberto D; Vanini V; Petruccioli E; Dieli F; Goletti D; Caccamo N
    Immunol Lett; 2015 Aug; 166(2):87-91. PubMed ID: 26051682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum exosome tRFs as a promising biomarker for active tuberculosis and latent tuberculosis infection.
    Xi X; Wang B; Zhang R; Ling C
    J Microbiol Methods; 2024 Jul; 222():106944. PubMed ID: 38705210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of Serum Biomarkers for Distinguishing between Latent and Active Tuberculosis Using Proteome Microarray.
    Cao SH; Chen YQ; Sun Y; Liu Y; Zheng SH; Zhang ZG; Li CY
    Biomed Environ Sci; 2018 Jul; 31(7):515-526. PubMed ID: 30145986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplex analysis of plasma cytokines/chemokines showing different immune responses in active TB patients, latent TB infection and healthy participants.
    Yao X; Liu Y; Liu Y; Liu W; Ye Z; Zheng C; Ge S
    Tuberculosis (Edinb); 2017 Dec; 107():88-94. PubMed ID: 29050777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple cytokine responses in discriminating between active tuberculosis and latent tuberculosis infection.
    Wu J; Wang S; Lu C; Shao L; Gao Y; Zhou Z; Huang H; Zhang Y; Zhang W
    Tuberculosis (Edinb); 2017 Jan; 102():68-75. PubMed ID: 28061954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PMN-MDSC Frequency Discriminates Active Versus Latent Tuberculosis and Could Play a Role in Counteracting the Immune-Mediated Lung Damage in Active Disease.
    Grassi G; Vanini V; De Santis F; Romagnoli A; Aiello A; Casetti R; Cimini E; Bordoni V; Notari S; Cuzzi G; Mosti S; Gualano G; Palmieri F; Fraziano M; Goletti D; Agrati C; Sacchi A
    Front Immunol; 2021; 12():594376. PubMed ID: 33981297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.